Duration: 2020 - ongoing
Influenza – Monitoring Vaccine Effectiveness in Europe on COVID-19. A project by the COVID-19-consortium in the I-MOVE network.
Project I-MOVE COVID-19
Duration: 2020 - ongoing
In working together in the I-MOVE COVID-19 consortium, established in 2020, many partners of the I-MOVE network (existing since 2007) obtain epidemiological, clinical and virological information on COVID-19 and patients infected with SARS-CoV-2 in a high quality, efficient and rapid way.
In obtaining this information on COVID-19 and patients infected with SARS-CoV-2, the I-MOVE COVID-19 consortium aims to contribute to knowledge about COVID-19, to better patient care and to protect public health. To this end, the existing, long-term, European influenza surveillance network (I-MOVE) is adapted and expanded with COVID-19. I-MOVE includes networks within primary care, hospitals and national reference laboratories in ten countries.
The consortium makes use of a flexible surveillance platform (adaptable to the epidemiological situation), of research and of hypothesis testing and evaluation of public health interventions (for example vaccination or antivirals). The prioritization of activities and research projects within I-MOVE COVID-19 are selected from a detailed list in the proposal, based on input from ECDC and WHO. These activities are realised by mobilizing an existing large European multidisciplinary network, by combining the expertise and resources of groups working in the field of surveillance (epidemiological, clinical, virological) research on respiratory diseases and by the evaluation of vaccines / treatments.
By sharing and pooling European results according to an established protocol, questions will be answered that otherwise cannot be efficiently answered by individual countries. I-MOVE COVID-19 will quickly and widely share the study results with national and international partners and with science. On doing so the consortium makes a contribution to patient care and to the prevention and control of COVID-19.
This project is a collaboration between Nivel, Epiconcept (Paris) and several European partners.
Nivel project team
Participating Nivel researchers are:
- Joke Korevaar PhD, coordinator Nivel research program General Practice Care
- Mariëtte Hooiveld PhD, senior researcher Nivel
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003673.
Want to know more?
Take a look at the international project website I-MOVE COVID-19.eu. And please feel free to get in touch with the Nivel expert(s) involved. You will find them on the right, together with the (future) Nivel deliverables (publications) and other relevant content.